C12N 2795/10211
Podoviridae
C12N2795/10211 (Podoviridae) appears on 116 US grants and 177 published applications in this corpus.
Search patents in C12N- Granted patents
- 116
- Published applications
- 177
- Assignees
- 114
- Inventors
- 367
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 1 |
| 2004 | 1 | 6 |
| 2005 | 0 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 3 |
| 2009 | 3 | 6 |
| 2010 | 0 | 5 |
| 2011 | 2 | 7 |
| 2012 | 7 | 5 |
| 2013 | 2 | 2 |
| 2014 | 0 | 5 |
| 2015 | 6 | 11 |
| 2016 | 6 | 9 |
| 2017 | 3 | 8 |
| 2018 | 5 | 12 |
| 2019 | 13 | 16 |
| 2020 | 10 | 7 |
| 2021 | 9 | 14 |
| 2022 | 7 | 10 |
| 2023 | 9 | 9 |
| 2024 | 9 | 17 |
| 2025 | 6 | 8 |
| 2026 | 4 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2795/10221Viruses as suchIndexing code52
- C12N 2795/10222New viral proteins or individual genes, new structural or functional aspects ofIndexing code46
- C12N 2795/10232Use of virus as therapeutic agent, other than vaccineIndexing code39
- C12N 2795/10231Uses of virus other than therapeutic or vaccineIndexing code28
- C12N 2795/10241Use of virus, viral particle or viral elements as a vectorIndexing code27
- C12N 2795/10271Demonstrated in vivo effectIndexing code14
- C12N 2795/10251Methods of production or purification of viral materialIndexing code12
- C12N 2795/10233Use of viral protein as therapeutic agent other than vaccineIndexing code9
Recent patents
- Methods and systems for the rapid detection of Listeria using infectious agents28 Jul 2026US 12,692,482 B2Laboratory Corporation of America Holdings
- Bacteriophage, bacterial wilt disease control agent, and bacterial wilt disease control method14 Apr 2026US 12,599,142 B2Panefri Industrial Co., Ltd.
- Bacteriophage compositions for treating Pseudomonas infection7 Apr 2026US 12,594,312 B2Armata Pharmaceuticals, Inc.
- Bacteriophage compositions and methods for treatment of bacterial infections17 Mar 2026US 12,576,119 B2Baylor College of Medicine
- Bacteriophage treatment and reduction in inflammatory response14 Oct 2025US 12,440,524 B2The Wetmead Institute for Medical Research
- Methods and compositions for nucleic acid synthesis24 Sep 2026US 2026/0286415 A1Primrose Bio, Inc.
- Bacteriophages and use thereof for the treatment or prevention of infection caused by salmonella gallinarum23 Jul 2026US 2026/0207687 A1Purdue Research Foundation
- Crop treatment16 Jul 2026US 2026/0198510 A1APS Biocontrol Limited
- Disposable personal care products composed of nonwoven fabrics coated with bacteriophages to prevent and reduce bacterially caused skin problems9 Jul 2026US 2026/0191922 A1Parallel Health, Inc.
- Methods and Systems for the Rapid Detection of Microorganisms Using Recombinant Infectious Agents to Express an Indicator Subunit25 Jun 2026US 2026/0176667 A1Laboratory Corporation of America Holdings
Most cited
By later US patents
- Inducible nitric oxide synthase gene for treatment of disease36US 5,658,565 AUniversity of Pittsburgh—Of the Commonwealth System of Higher Education · 1997
- Phage therapy against Pseudomonas aeruginosa30US 8,282,920 B2Industry-University Cooperation Foundation Sogang University · 2012
- Engineered enzymatically active bacteriophage and methods for dispersing biofilms20US 8,153,119 B2Massachusetts Institute of Technology · 2012
- Process for bacterial production of polypeptides19US 6,258,560 B1Genentech, Inc. · 2001
- Stable mammalian cell line expressing a bacteriophage RNA polymerase17US 5,126,251 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 1992